About this trial
The incidence of postoperative acute kidney injury (AKI) is high in patients undergoing lung resection surgery, especially in the elderly. Early identification of high-risk postoperative AKI patients can help develop prevention and treatment management strategies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged ≥ 65 years
lung resection surgery including:pneumonectomy , bilobectomy , lobectomy, segmentectomy, wedge resection/bullectomy.
Disqualifiers
patients with an American Society of Anesthesiologists (ASA) physical status V.
those with end-stage renal disease (i.e. a glomerular filtration rate of 15 mL/min/1.73 m2 or receiving haemodialysis).
those did not have sufficient data required for nutritional evaluation or AKI evaluation.
Trial population
Older patients (aged ≥ 65 years) who underwent lung resection surgery under general anesthesia at our Hospital between January 2020 and June 2024 were included in our study. Lung resection surgery included pneumonectomy , bilobectomy , lobectomy, segmentectomy, wedge resection/bullectomy.
Trial design
Cohort
Retrospective
Treatments tested in this trial
no intervention
Other interventionno intervention
Treatment groups
Trial outcomes
Primary outcomes
Postoperative acute kidney injury
In accordance with the KDIGO creatinine criteria: a serum creatinine increases of 26.5 mmol/L within 48 hours or 1.5 times baseline within 7 days after surgery.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Wanmin Liao
Lead sponsor
Tongji Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: